GSK plc Share Buyback Transaction on 29 July 2025

SEC Filing 6-K (0001654954-25-008623)

GSK plc announced the purchase of 490,615 of its ordinary shares at a volume-weighted average price of 1,398.63p per share on 29 July 2025. The shares were bought through Merrill Lynch International as part of the company's existing buyback program. The lowest price paid was 1,385.00p, and the highest price was 1,405.00p. Following this transaction, GSK plc holds 236,281,343 ordinary shares in treasury and has 4,079,104,067 ordinary shares in issue, excluding treasury shares. The total number of voting rights in the company is 4,079,104,067, with 5.79% of voting rights attributable to the treasury shares.